Recruiting PHASE2 INTERVENTIONAL 1-arm NCT05996003

NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)

A Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NS-089/NCNP-02 in Boys With Duchenne Muscular Dystrophy (DMD)

Sponsor: NS Pharma, Inc.

Conditions DMD Duchenne Muscular Dystrophy Exon 44

Interventions NS-089/NCNP-02

Updated 10 times since 2023 Last updated: Mar 4, 2026 Started: Feb 22, 2024 Primary completion: Sep 11, 2026 Completion: Sep 11, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05996003, this PHASE2 trial focuses on DMD and Duchenne Muscular Dystrophy and remains actively recruiting participants. Sponsored by NS Pharma, Inc., it has been updated 10 times since 2024, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Mar 2026 — Present [monthly]

Recruiting PHASE2
Jan 2026 — Mar 2026 [monthly]

Recruiting PHASE2
Oct 2025 — Jan 2026 [monthly]

Recruiting PHASE2
Jul 2025 — Oct 2025 [monthly]

Recruiting PHASE2
Dec 2024 — Jul 2025 [monthly]

Recruiting PHASE2

▶ Show 5 earlier versions

Sep 2024 — Dec 2024 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE2
Feb 2024 — Apr 2024 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Sep 2023 — Feb 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NS Pharma, Inc.
Nippon Shinyaku Co., Ltd.

Data source: NS Pharma, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ankara, Turkey (Türkiye) , Atlanta, United States , Auckland, New Zealand , Aurora, United States , Calgary, Canada , Chicago, United States , Cincinnati, United States , Dallas, United States , Fukui-shi, Japan , Istanbul, Turkey (Türkiye) and 15 more locations